Can pre-therapy 68Ga-PSMA-11 PET SUVs predict absorbed doses across multiple cycles of 177Lu-PSMA-617 therapy of mCRPC patients?

被引：0
|
作者：
Brosch-Lenz, J. [1 ]
Colpo, N. [2 ]
Bloise, I. [1 ]
Hou, X. [1 ]
Parulekar, W. R. [3 ]
Dellar, C. [3 ]
Saad, F. [4 ]
Chi, K. [2 ]
Wilson, D. [2 ]
Benard, F. [2 ]
Rahmim, A. [1 ]
Uribe, C. [2 ]
机构：
[1] BC Canc, Res Inst, Vancouver, BC, Canada
[2] BC Canc, Vancouver, BC, Canada
[3] Queens Univ Kingston, Canadian Canc Trials Grp, Kingston, ON, Canada
[4] CRCHUM, Inst Canc Montreal, Prostate Canc Res, Montreal, PQ, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-715
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [1] Predicting cycle 1 salivary gland absorbed dose before 177Lu-PSMA-617 radioligand therapy using pre-therapy 68Ga-PSMA-11 PET uptake metrics
    Fitzpatrick, K.
    Arunachalam, R.
    Wang, C.
    Roseland, M.
    Wong, K.
    Dewaraja, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S164 - S165
  • [2] Single 68Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organ and tumour lesions in 177Lu-PSMA-617 treatment
    Nautiyal, A.
    Pitkin, I.
    Jha, A. K.
    Srichandan, T.
    Mithun, S.
    Konuparamban, A.
    Rangarajan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S642 - S643
  • [3] Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection
    Yadav, Surekha
    Kim, Sarasa T.
    Tuchayi, Abuzar Moradi
    Jiang, Fei
    Morley, Amanda
    Saelee, Rachelle
    Wang, Yingbing
    Juarez, Roxanna
    Lawnh-Heath, Courtney
    Koshkin, Vadim S.
    Hope, Thomas A.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis
    Roll, Wolfgang
    Schindler, Philipp
    Masthoff, Max
    Seifert, Robert
    Schlack, Katrin
    Bogemann, Martin
    Stegger, Lars
    Weckesser, Matthias
    Rahbar, Kambiz
    CANCERS, 2021, 13 (15)
  • [5] Correlation of PSMA PET and Post-therapy SPECT Imaging Metrics with Absorbed Doses for 177Lu-PSMA-617 Therapy
    Meyer, Catherine
    Yilmaz, Burcak
    Winters, Celeste
    Mench, Anna
    Mallak, Nadine
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [6] VISION read criteria of 68Ga-PSMA-11 PET scans for patient eligibility to 177Lu-PSMA-617 therapy: a simple and reproducible methodology
    Kuo, P.
    Yoo, D. C.
    Avery, R.
    Seltzer, M.
    Calais, J.
    Nagarajah, J.
    Weber, W. A.
    Fendler, W. P.
    Hofman, M. S.
    Krause, B. J.
    Catafau, A.
    Kpamegan, E.
    Brackman, M.
    Kendi, A. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S129 - S130
  • [7] 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
    Christoph A. Umbricht
    Martina Benešová
    Raffaella M. Schmid
    Andreas Türler
    Roger Schibli
    Nicholas P. van der Meulen
    Cristina Müller
    EJNMMI Research, 7
  • [8] Tumor-to-liver ratio (TLR) by 68Ga-PSMA-11 PET/CT for response assessment and prediction of progressionfree survival in patients with mCRPC undergoing 177Lu-PSMA-617 radioligand therapy
    Khreish, F.
    Wiessner, M.
    Rosar, F.
    Ghazal, Z.
    Sabet, A.
    Maus, S.
    Linxweiler, J.
    Bartholomae, M.
    Ezziddin, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S314 - S314
  • [9] Initial Theranostics Experience Using 68Ga-PSMA-11 PET/CT and 177Lu-PSMA-617 in a Chilean Oncology Center
    Amaral, H.
    Fernandez, R.
    Kramer, V.
    Lavados, H.
    Hernandez, E.
    Morales, B.
    Pruzzo, R.
    Haeger, A.
    Ribbeck, J.
    Flores, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S205 - S205
  • [10] Does Pre-Therapy PSA Influence 177Lu-PSMA-617 Treatment Outcomes?
    Fermawi, S.
    Buehner, T.
    Kalarn, S.
    Sabottke, C.
    Recio-Boiles, A.
    Savir-Baruch, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S363 - S363
12345